Hmc Capital Limited · ASX:HMC

Hmc Capital — Investor Presentation (June 2024)

4 slides from Hmc Capital's investor presentation, Jun 30, 2024

  1. Slide 1: HMC Capital Partners Fund 1 Case Study: Sigma Healthcare

    HM Capital HMC Capital Partners Fund | Case Study: Sigma Healthcare 30 June 2024

  2. Slide 2: Sigma Healthcare: value creation over the Fund's investment

    Sigma Healthcare HMCCP Fund 1 has helped investee company Sigma Healthcare create significant value for shareholders during the period of our investment Value creation in Sigma over the course of the Fund’s investment ▪ HMCCP Fund 1 holds a ~15% interest in Sigma Healthcare Limited (ASX: SIG) ("Sigm

  3. Slide 3: Transformational Merger between Sigma and Chemist Warehouse

    Sigma Healthcare Transformational Merger between Sigma and Chemist Warehouse Transaction Summary1 Investment Highlights of the Merged Group3 ▪ Transformational merger proposed between Sigma and Chemist Warehouse Group (“CWG”) to create an $8bn+ leading healthcare ▪ National full line pharmaceutical

  4. Slide 4: Disclaimer

    Disclaimer This presentation (Presentation) has been prepared by HMC Capital Limited (ACN 138 990 593) (“HMC Capital”) Summary information This document does not constitute, and may not be used for the purposes of, an offer of securities or interests of any kind to any person or an invitation to any

HMC Capital — Investor Presentation (June 2024) on 6ix